T

TScan Therapeutics Inc
NASDAQ:TCRX

Watchlist Manager
TScan Therapeutics Inc
NASDAQ:TCRX
Watchlist
Price: 2.63 USD -3.31% Market Closed
Market Cap: 140.4m USD

TScan Therapeutics Inc
Investor Relations

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. The company is headquartered in Waltham, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2021-07-16. The firm is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer. The firm's lead liquid tumor TCR-T therapy candidates include TSC-100 and TSC-101, which are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation (HCT). TSC-100 and TSC-101 targets histocompatibility antigens (HA)-1 and HA-2 antigens, respectively. TScan solid tumor product candidates include TSC-200, TSC-201, TSC-202 and TSC-203. Its TSC-200 series of product candidates are being developed to treat both HPV-positive and HPV-negative tumors. The firm's platform technologies include TargetScan, ReceptorScan and T-Integrate.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Dr. Gavin MacBeath Ph.D.
CEO & Director
No Bio Available
Dr. Zoran Zdraveski J.D., Ph.D.
Chief Legal & Strategy Officer and Company Secretary
No Bio Available
Dr. Stephen J. Elledge Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
No Bio Available
Mr. Tomasz Kula Ph.D.
Co-Founder & Member of Advisory Board
No Bio Available
Mr. Jason A. Amello CPA
CFO & Treasurer
No Bio Available
Dr. Justin McCue Ph.D.
Chief Technology Officer
No Bio Available
Ms. Ann Hargraves
Senior Vice President of Human Resources
No Bio Available
Dr. Shrikanta Chattopadhyay M.D.
Senior VP & Head of Translational Medicine
No Bio Available
Mr. Ray Lockard M.B.A.
Senior Vice President & Head of Quality
No Bio Available
Mr. Jim Murray
Senior VP & Head of Development Operations
No Bio Available

Contacts

Address
MASSACHUSETTS
Waltham
830 Winter Street
Contacts
+18573999500.0
www.tscan.com